Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS stands by Part D deadline

Executive Summary

May 15 is likely to remain the deadline for enrollment in Medicare Part D, HHS Secretary Michael Leavitt stated during the America's Health Insurance Plans National Policy Forum March 7. "We believe that the May 15 deadline is an appropriate deadline," he said. Leavitt, however, noted that "Congress could change the deadline." Some legislators have called for an extension of the Medicare drug benefit enrollment period because of implementation challenges. For beneficiaries signing up for Part D after May 15, a penalty of 1% of the base premium will be assessed for every month that enrollment is delayed...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel